Agilent Technologies (A) EBT Margin (2010 - 2026)
Agilent Technologies' (A) quarterly EBT Margin came in at 23.64% in Q3 2026, up 258.0% year-over-year from 6.6% in Q3 2025, and up 6.33% quarter-over-quarter from 22.23% in Q2 2026.
Analysis
Agilent Technologies (A) EBT Margin (2010 - 2026) Analysis & Trends
Agilent Technologies (A) has reported EBT Margin for 17 consecutive years, with 23.64% the latest figure, recorded in Q3 2026.
- On a quarterly basis, EBT Margin rose 258.0% year-over-year to 23.64% in Q3 2026; TTM through Jul 2026 was 22.49%, a 195.0% increase from a year earlier, with the FY2025 full-year figure at 20.65%, down 271.0% from the prior year.
- EBT Margin was 23.64% for Q3 2026 at Agilent Technologies, up from 22.23% in the prior quarter.
- Over five years, EBT Margin peaked at 24.88% in Q4 2023 and troughed at 7.89% in Q3 2023.
- A 5-year average of 21.44% and a median of 22.23% in 2026 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin sank 1521 bps in 2023 and surged 1384 bps in 2024, its largest moves.
- Over 5 years, EBT Margin stood at 24.61% in 2022, then advanced by 1 bps to 24.88% in 2023, then declined by 5 bps to 23.57% in 2024, then climbed by 1 bps to 23.75% in 2025, then fell by 0 bps to 23.64% in 2026.
- The last three EBT Margin figures came in at 23.64% (Q3 2026), 22.23% (Q2 2026), and 20.24% (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 17.21% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 22.43% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 8.71% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 22.01% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 83.27% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 6.93% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -12.34% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -6.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 23.64% |
| Apr 30, 2026 | 22.23% |
| Jan 31, 2026 | 20.24% |
| Oct 31, 2025 | 23.75% |
| Jul 31, 2025 | 21.06% |
| Apr 30, 2025 | 15.59% |
| Jan 31, 2025 | 21.83% |
| Oct 31, 2024 | 23.57% |
| Jul 31, 2024 | 21.74% |
| Apr 30, 2024 | 23.78% |
| Jan 31, 2024 | 24.31% |
| Oct 31, 2023 | 24.88% |
| Jul 31, 2023 | 7.89% |
| Apr 30, 2023 | 21.96% |
| Jan 31, 2023 | 23.35% |
| Oct 31, 2022 | 24.61% |
| Jul 31, 2022 | 23.11% |
| Apr 30, 2022 | 20.72% |
| Jan 31, 2022 | 19.06% |
| Oct 31, 2021 | 26.99% |